Cargando…
Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer
The incidence of breast cancer continues to rise: 1.7 million women were diagnosed with and 521,000 women died from breast cancer in 2012. This review considers first current treatment options: surgery; radiotherapy; and systemic endocrine, anti-biological, and cytotoxic therapies. Clinical manageme...
Autor principal: | May, Felicity EB |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041375/ https://www.ncbi.nlm.nih.gov/pubmed/24904222 http://dx.doi.org/10.2147/CMAR.S35024 |
Ejemplares similares
-
The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors
por: Gu, Yu, et al.
Publicado: (2014) -
The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004) -
High estrogen receptor alpha activation confers resistance to estrogen deprivation and is required for therapeutic response to estrogen in breast cancer
por: Traphagen, Nicole A., et al.
Publicado: (2021) -
Discovery of Targets for Immune–Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha
por: Sahu, Avinash, et al.
Publicado: (2023) -
Estrogen-Related Receptor Alpha: An Under-Appreciated Potential Target for the Treatment of Metabolic Diseases
por: Tripathi, Madhulika, et al.
Publicado: (2020)